Superworth

Arbutus Biopharma EPS ABUS

Diluted earnings per share by quarter and over the last twelve months, from 2013.

Last 12 months, to Jun 30, 2026
$0.78
Latest quarter, Q2 FY26
−$0.03
−400% on a year earlier
Fiscal year 2025
−$0.18

Arbutus Biopharma's earnings per share was $0.78 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$0.03, down 400% on the same quarter a year before.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$0.18n/a
FY2024−$0.38n/a
FY2023−$0.43n/a
FY2022−$0.47n/a
FY2021−$0.84n/a
FY2020−$1.00n/a
FY2019−$2.90n/a
FY2018−$1.22n/a
FY2017−$1.55n/a
FY2016−$7.16n/a
FY2015−$1.34n/a
FY2014−$1.86n/a
FY2013−$0.94n/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26−$0.03−400%$0.78
Q1 FY26$0.87n/a$0.82
Q4 FY25−$0.02n/a−$0.18
Q3 FY25−$0.04n/a−$0.23
Q2 FY25$0.01n/a−$0.29
Q1 FY25−$0.13n/a−$0.41
Q4 FY24−$0.07n/a−$0.38
Q3 FY24−$0.10n/a−$0.42
Q2 FY24−$0.11n/a−$0.44
Q1 FY24−$0.10n/a−$0.43
Q4 FY23−$0.11n/a−$0.43
Q3 FY23−$0.12n/a−$0.46

Against its peers

Companies in Drug Manufacturers - General nearest Arbutus Biopharma's size, closest first, today.

CompanyEPS, 12 monthsGrowth
ABUSArbutus Biopharma$0.78
COLLCollegium Pharmaceutical$1.24+19% a year
AMPHAmphastar Pharmaceuticals$1.70−36% a year
CRMDCorMedix$2.13+184% a year
ZVRAZevra Therapeutics$0.93
OMEROmeros$1.52
IRWDIronwood Pharmaceuticals$0.77
PBYIPuma Biotechnology$0.52−47% a year
ARVNArvinas$0.16
PCRXPacira BioSciences$0.35
ANABAnaptysbio$4.57
Peer median$1.08

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Arbutus Biopharma

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.